RESUMEN
Pyridoxine is an important co-factor for many biochemical reactions in cellular metabolism related to the synthesis and catabolism of amino acids, fatty acids, neurotransmitters. Deficiency of pyridoxine results in impaired transcellular signaling between neurons and presents with muscular convulsions, hyperirritability, and peripheral neuropathy. Deficiency of pyridoxine is usually found in association with other vitamin B deficiencies such as folate (vitamin B9) and cobalamin (vitamin B12). Isolated pyridoxine deficiency is extremely rare. We present the case of a 59-year old female with type 2 diabetes who complained of painful muscle spasms. Her muscle spasms involved in both feet, which have spread proximally to her legs. She also experienced intermittent muscle spasms in her left arm, which is not alleviated by baclofen, cyclobenzaprine. Her plasma pyridoxal 5-phosphate confirmed pyridoxine deficiency. Vitamins B1, B3, B12, and folate were within normal limits. The patient received standard-dose intramuscular pyridoxine injections for three weeks followed by oral supplements for 3 months and her symptoms resolved. This case illustrates the rare instance of isolated pyridoxine deficiency in type 2 diabetes patient manifesting as myoclonic muscle spasms involving the legs and arms in the absence of objective polyneuropathy. Pyridoxine level should, therefore, be assessed in patients with type 2 diabetes, including newly diagnosed patients.
Asunto(s)
Diabetes Mellitus Tipo 2/sangre , Piridoxina/sangre , Espasmo/sangre , Deficiencia de Vitamina B 6/sangre , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diagnóstico Diferencial , Femenino , Humanos , Persona de Mediana Edad , Piridoxina/administración & dosificación , Piridoxina/deficiencia , Espasmo/diagnóstico , Espasmo/tratamiento farmacológico , Deficiencia de Vitamina B 6/diagnóstico , Deficiencia de Vitamina B 6/tratamiento farmacológicoRESUMEN
A 39-year-old woman with a history of Roux-en-Y gastric bypass (RYGB) surgery and alcohol use presented with a confluent erythematous rash involving the perineum spreading outward to the abdomen, thighs and lower back. She had angular cheilitis and glossitis. The rash was painful and blistering in scattered areas. She was hypotensive and appeared to be in septic or hypovolemic shock at presentation. Serum levels of zinc and vitamin B6 were critically low and biopsy of her rash returned suggestive of a nutritional deficiency as its source. The rash slowly improved over the following 2 weeks with oral zinc and vitamin B6 replacement. The body rash resembled that of infants born with inherited defects in zinc transporters, referred to as acrodermatitis enteropathica (AE). This case may represent an acquired case of AE in the setting of prior RYGB.
Asunto(s)
Deficiencia de Vitamina B 6/diagnóstico , Vitamina B 6/administración & dosificación , Zinc/administración & dosificación , Zinc/deficiencia , Administración Oral , Adulto , Biopsia , Queilitis/etiología , Exantema/etiología , Derivación Gástrica/efectos adversos , Humanos , Resultado del Tratamiento , Vitamina B 6/uso terapéutico , Deficiencia de Vitamina B 6/tratamiento farmacológicoRESUMEN
INTRODUCTION: Sideroblastic anemia is a rare cause of microcytic anemia, which is characterized by ring sideroblasts on bone marrow aspirate. This anemia can be congenital or acquired. CASE REPORT: We report the case of an alcoholic 49-year-old man who presented with a severe microcytic sideroblastic anemia related to pyridoxine (B6 vitamin) deficiency. Acid folic deficiency was associated. The blood count normalized within one month after vitamin supplementation. CONCLUSION: Pyridoxine deficiency must be sought in sideroblastic anemia in patients at risk.
Asunto(s)
Anemia Sideroblástica/tratamiento farmacológico , Deficiencia de Vitamina B 6/tratamiento farmacológico , Vitamina B 6/uso terapéutico , Alcoholismo/complicaciones , Alcoholismo/diagnóstico , Alcoholismo/tratamiento farmacológico , Anemia Sideroblástica/complicaciones , Anemia Sideroblástica/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , Deficiencia de Vitamina B 6/complicaciones , Deficiencia de Vitamina B 6/diagnósticoRESUMEN
OBJECTIVES: We investigated vitamin B6 blood concentrations in children on long-term dialysis at our centre. METHODS: Retrospective cross-sectional review of vitamin B6 blood concentrations in children on maintenance dialysis [peritoneal dialysis (PD), intermittent haemodialysis (IHD)]. RESULTS: We reviewed 28 children (16 boys), 15 IHD and 13 PD with median (interquartile range, IQR) age of 9.4 (2.4, 14.3) years. The median (IQR) vitamin B6 concentration was 223.4 (74.2, 392.8) nmol/L measured a median (IQR) of 9 (4, 16.5) months following commencement of dialysis. None of the children had vitamin B6 deficiency. Vitamin B6 concentrations were raised in 17 (61%), eight of these received a supplement. Nineteen (68%) received vitamin B6 and/or a supplement containing vitamin B6 whilst 11 (39%) received an enteral feed and a supplement. In those with normal vitamin B6 concentrations who were not receiving an enteral feed or an oral nutritional supplement (n = 6), all achieved normal concentrations without need for vitamin B6 supplementation. There were no differences between those on PD versus IHD (269.2 nmol/L vs. 130 nmol/L, P = 0.65). CONCLUSIONS: We report no children with vitamin B6 deficiency although > 50% had elevated vitamin B6 concentrations. We suggest if dietary assessment of vitamin B6 intake indicates insufficient intake, measurement of blood concentrations will help confirm if supplementation is required. Routine vitamin B6 supplementation and monitoring is currently not indicated in children on chronic dialysis.
Asunto(s)
Suplementos Dietéticos , Diálisis Renal/efectos adversos , Insuficiencia Renal Crónica/terapia , Deficiencia de Vitamina B 6/sangre , Vitamina B 6/sangre , Adolescente , Niño , Preescolar , Estudios Transversales , Femenino , Humanos , Lactante , Masculino , Insuficiencia Renal Crónica/complicaciones , Estudios Retrospectivos , Deficiencia de Vitamina B 6/diagnóstico , Deficiencia de Vitamina B 6/etiología , Deficiencia de Vitamina B 6/prevención & controlRESUMEN
Low periconceptional vitamin B6 (B6) status has been associated with an increased risk of preterm birth and early pregnancy loss. Given many pregnancies are unplanned; it is important for women to maintain an adequate B6 status throughout reproductive years. There is limited data on B6 status in Canadian women. This study aimed to assess the prevalence of B6 deficiency and predictors of B6 status in young adult women in Metro Vancouver. We included a convenience sample of young adult non-pregnant women (19-35 years; n = 202). Vitamin B6 status was determined using fasting plasma concentrations of pyridoxal 5'-phosphate (PLP). Mean (95% confidence interval) plasma PLP concentration was 61.0 (55.2, 67.3) nmol/L. The prevalence of B6 deficiency (plasma PLP < 20 nmol/L) was 1.5% and that of suboptimal B6 status (plasma PLP = 20-30 nmol/L) was 10.9%. Body mass index, South Asian ethnicity, relative dietary B6 intake, and the use of supplemental B6 were significant predictors of plasma PLP. The combined 12.4% prevalence of B6 deficiency and suboptimal status was lower than data reported in US populations and might be due to the high socioeconomic status of our sample. More research is warranted to determine B6 status in the general Canadian population.
Asunto(s)
Fosfato de Piridoxal/sangre , Salud Urbana , Deficiencia de Vitamina B 6/epidemiología , Salud de la Mujer , Adulto , Factores de Edad , Biomarcadores/sangre , Colombia Británica/epidemiología , Estudios Transversales , Femenino , Estado de Salud , Encuestas Epidemiológicas , Humanos , Modelos Lineales , Análisis Multivariante , Prevalencia , Factores de Riesgo , Factores Sexuales , Deficiencia de Vitamina B 6/sangre , Deficiencia de Vitamina B 6/diagnóstico , Adulto JovenRESUMEN
SETTING: Distal sensory polyneuropathy (DSP) may manifest in human immunodeficiency virus (HIV) infected individuals before or after antiretroviral therapy (ART). DSP can also occur in response to isoniazid (INH); this can be prevented by pyridoxine supplementation. N-acetyltransferase 2 (NAT2) polymorphisms influence drug acetylation and possibly the risk for INH-associated DSP. OBJECTIVE: To investigate the relationship between previous/current TB, pyridoxine deficiency and DSP in HIV-infected individuals enrolled in a government-sponsored HIV programme. DESIGN: Neuropathy assessments were performed among 159 adults pre-ART and 12 and 24 weeks thereafter. DSP was defined as ⩾1 neuropathic symptom and sign. NAT2 genotypes predicted acetylation phenotype. Serum pyridoxine levels (PLP) were quantified at baseline and week 12. RESULTS: DSP was present in 16% of individuals pre-ART and was associated with previous/current TB (P = 0.020). Over 50% were pyridoxine deficient (PLP < 25 nmol/l), despite supplementation with vitamin B complex supplements (2-4 mg/day pyridoxine). Those with a history of TB and pre-ART DSP were more likely to be pyridoxine deficient (P = 0.029), and slow/intermediate NAT2 phenotypes impacted on their PLP levels. Incident/worsening DSP after ART developed in 21% of the participants. PLP levels remained low after ART, particularly among those with prior TB, but without an association between DSP or NAT2 phenotypes. CONCLUSION: Adequate pyridoxine supplementation before ART initiation should be prioritised, particularly in those with a history of TB or current TB.
Asunto(s)
Isoniazida/efectos adversos , Polineuropatías/diagnóstico , Polineuropatías/tratamiento farmacológico , Piridoxina/sangre , Deficiencia de Vitamina B 6/diagnóstico , Complejo Vitamínico B/uso terapéutico , Adulto , Terapia Antirretroviral Altamente Activa , Arilamina N-Acetiltransferasa/genética , Coinfección/tratamiento farmacológico , Femenino , Infecciones por VIH/tratamiento farmacológico , Humanos , Isoniazida/uso terapéutico , Masculino , Factores de Riesgo , Sudáfrica , Tuberculosis/tratamiento farmacológicoRESUMEN
Micronutrient deficiencies such as vitamin A, iron, zinc, and selenium have been known to occur as a consequence of pancreaticoduodenectomy (PD), but vitamin B6 deficiency has not been previously reported. We report two post-PD patients who developed anemias attributed to vitamin B6 deficiency. Oral supplementations of vitamin B6 significantly improved anemias in both cases. Micronutrients including vitamin B6 should be monitored in post-PD patients, and supplementations should be carried out when necessary.
Asunto(s)
Anemia/etiología , Pancreaticoduodenectomía , Complicaciones Posoperatorias/etiología , Deficiencia de Vitamina B 6/etiología , Anemia/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/diagnóstico , Deficiencia de Vitamina B 6/diagnósticoRESUMEN
SETTING: Human immunodeficiency virus (HIV) infection and treatments for HIV infection and tuberculosis (TB) are associated with the risk of developing sensory polyneuropathy (SPN). Vitamin B6 and genetically determined slow isoniazid (INH) acetylation are believed to play key roles in the development of SPN in a TB treatment setting. OBJECTIVE: To investigate slow acetylation and risk factors for SPN in HIV-infected patients receiving TB treatment, and establish vitamin B6 status and its association with SPN. METHODS: HIV-infected in-patients were prospectively assessed after initiating TB treatment and vitamin B6 supplementation, and monthly during hospitalisation. SPN was defined as ≥1 symptom plus ≥1 sign. NAT2 genotyping predicted acetylation status, and plasma high performance liquid chromatography estimated vitamin B6 status. A survival analysis estimated hazard ratios (HRs) for SPN during TB treatment. RESULTS: Of 116 participants, 56% had SPN at study entry. Participants developed SPN at a rate of 26/100 person-months (95%CI 18-35) during TB treatment, which was independently associated with slow acetylation (HR 2.5; 95%CI 1.1-5.9), as well as black race, previous TB and extra-pulmonary/disseminated TB. Vitamin B6 status was normal, irrespective of SPN. CONCLUSIONS: Risk factors for SPN suggest a multi-factorial pathogenesis related to INH and other potential nervous system insults. SPN developed despite normal vitamin B6 status, suggesting other mechanisms of injury.
Asunto(s)
Antituberculosos/efectos adversos , Infecciones por VIH/complicaciones , Polineuropatías/inducido químicamente , Células Receptoras Sensoriales , Tuberculosis Pulmonar/tratamiento farmacológico , Acetilación , Adulto , Arilamina N-Acetiltransferasa/genética , Arilamina N-Acetiltransferasa/metabolismo , Suplementos Dietéticos , Femenino , Genotipo , Infecciones por VIH/diagnóstico , Infecciones por VIH/mortalidad , Humanos , Estudios Longitudinales , Masculino , Fenotipo , Polineuropatías/diagnóstico , Polineuropatías/fisiopatología , Estudios Prospectivos , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento , Tuberculosis Pulmonar/complicaciones , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/microbiología , Tuberculosis Pulmonar/mortalidad , Vitamina B 6/sangre , Vitamina B 6/uso terapéutico , Deficiencia de Vitamina B 6/sangre , Deficiencia de Vitamina B 6/complicaciones , Deficiencia de Vitamina B 6/diagnóstico , Deficiencia de Vitamina B 6/tratamiento farmacológico , Vitaminas/uso terapéuticoRESUMEN
To date we know of four inborn errors of autosomal recessive inheritance that lead to vitamin B6-dependent seizures. Among these, pyridoxine-dependent seizures due to antiquitin deficiency is by far the most common, although exact incidence data are lacking. In PNPO deficiency, samples have to be collected prior to treatment, while PDE, hyperprolinemia type II and congenital HPP can be diagnosed while on vitamin B6 supplementation. A vitamin B6 withdrawal for diagnostic purposes is nowadays only indicated in patients with a clear vitamin B6 response but normal biochemical work-up. In the presence of therapy-resistant neonatal seizures, early consideration of a vitamin B6 trial over 3 consecutive days is crucial in order to prevent irreversible brain damage. While PLP would be effective in all four disorders, pyridoxine fails to treat seizures in PNPO deficiency. As PLP is unlicensed within Europe and North America, pyridoxine is widely used as the first line drug, but if it is ineffective it should be followed by a trial with PLP, especially in neonates. As severe apnea has been described in responders, resuscitation equipment should be at hand during a first pyridoxine/PLP administration. Patients and parents have to be informed about the lifelong dependency and recurrence risks in forthcoming pregnancies.
Asunto(s)
Encefalopatías Metabólicas/diagnóstico , Epilepsia/diagnóstico , Hipoxia-Isquemia Encefálica/diagnóstico , Piridoxaminafosfato Oxidasa/deficiencia , Convulsiones/diagnóstico , Deficiencia de Vitamina B 6/diagnóstico , Niño , Epilepsia/etiología , Humanos , Piridoxina/deficiencia , Piridoxina/uso terapéutico , Deficiencia de Vitamina B 6/complicaciones , Deficiencia de Vitamina B 6/tratamiento farmacológicoRESUMEN
BACKGROUND: Vitamin deficiency is a cause of health related problems in elderly people. The aims were to study associations between vitamin B6 (B6) and diseases (primarily functional gastrointestinal disorders) in elderly people in nursing homes, the prevalence of B6 deficiency and factors associated with B6 deficiency. METHODS: This cross-sectional study included residents in nursing homes. Demographics, nutritional status (Mini Nutritional Assessment, MNA®), physical activity, activity of daily living (Katz Index), dietary habits, use of drugs, and psychiatric and somatic diseases were recorded. A blood sample was collected for haematological and biochemical screening, including B6 (p-PLP); p-PLP values < 20 nmol/l indicates B6 deficiency. The results are given as mean (SD). RESULTS: Sixty-one residents (men/women: 22/39) with an age of 85.3 (6.8) years and BMI 25.7 (4.5) kg/m2 were included. Malnutrition and risk of malnutrition were present in 11.5% and 61% respectively. Dietary intake of B6 (mg/day) in men and women were 1.60 (0.30) and 1.18 (0.31) (recommended 1.6 and 1.2 respectively), and 14 (23%) used B6 supplements. Median p-PLP was 20.7 (range <4.0-175.8), 30 subjects (49%) had B6 deficiency. B6 deficiency was associated with old age, low s-alanine aminotransferase and s-albumin, elevated s-homocysteine and inactivity (p-values 0.01-0.03). There were no clinically significant associations between B6 deficiency and somatic or psychiatric disorders, and B6 deficiency was not observed in subjects given B6 supplements. CONCLUSIONS: Half of the residents had vitamin B6 deficiency. Vitamin supplement was effective prophylaxis for deficiency and should be recommended to all elderly people in nursing homes.
Asunto(s)
Hogares para Ancianos , Desnutrición/diagnóstico , Desnutrición/epidemiología , Casas de Salud , Deficiencia de Vitamina B 6/diagnóstico , Deficiencia de Vitamina B 6/epidemiología , Anciano , Anciano de 80 o más Años , Estudios Transversales , Registros de Dieta , Femenino , Hogares para Ancianos/tendencias , Humanos , Masculino , Desnutrición/terapia , Casas de Salud/tendencias , Vitamina B 6/administración & dosificación , Deficiencia de Vitamina B 6/terapiaRESUMEN
OBJECTIVE: To determine the plasma/serum levels of homocysteine, and vitamins folate, B6 and B12, in Pakistani healthy adults. STUDY DESIGN: Cross-sectional study. PLACE AND DURATION OF STUDY: The Aga Khan University, from October 2006 to April 2008. METHODOLOGY: Fasting levels of plasma/serum folic acid, pyridoxal phosphate (PLP), vitamin B12 and homocysteine were determined in 290 apparently healthy hospital personnel from institutions in two cities of Pakistan. Spearman correlation test and linear regression analysis was conducted. RESULTS: There were 219 males and 71 females with mean age of 46+/-10.5 years and mean body mass index of 23.5 +/-3.8. Mean plasma homocysteine levels in Pakistani normal adults were found to be 17.95+/-8.4 micromol/l. Mean concentrations of plasma/serum folate, vitamin B12 and PLP were found to be 5+/-3.9 ng/ml, 522+/-296 pg/ml and 21.6+/-14 nmol/l, respectively. Serum/plasma levels of folate, vitamin B12 and PLP were negatively correlated with plasma homocysteine (rho coefficient=-0.367, p<0.001; -0.173, p=0.004; -0.185, p=0.002, respectively). Serum folate and plasma PLP levels were inversely related with plasma homocysteine, adjusted for gender, age, smoking and body mass index (p<0.001 and p=0.003, respectively). Percent deficiency values of folate, vitamin B6 and vitamin B12 were 39.7%, 52.8% and 6.6% respectively. CONCLUSION: The high levels of plasma homocysteine could indicate a reason for mass micronutrient supplementation to prevent the high incidence of cardiovascular disease observed in Pakistani population.
Asunto(s)
Deficiencia de Ácido Fólico/epidemiología , Hiperhomocisteinemia/epidemiología , Deficiencia de Vitamina B 6/epidemiología , Adulto , Anciano , Estudios de Cohortes , Estudios Transversales , Suplementos Dietéticos , Femenino , Deficiencia de Ácido Fólico/diagnóstico , Deficiencia de Ácido Fólico/terapia , Humanos , Hiperhomocisteinemia/diagnóstico , Hiperhomocisteinemia/terapia , Masculino , Micronutrientes/uso terapéutico , Persona de Mediana Edad , Pakistán , Deficiencia de Vitamina B 6/diagnóstico , Deficiencia de Vitamina B 6/terapiaRESUMEN
It has been hypothesized that idiopathic carpal tunnel syndrome (CTS) is a manifestation of vitamin B6 deficiency. Some claim that B6 supplementation can alleviate symptoms. Others argue that pain relief occurs because of vitamin B6's anti-nociceptive properties or because B6 supplementation addresses an unrecognized peripheral neuropathy. Few studies on CTS and B6 employed electrodiagnostic techniques in diagnosis, and few showed a correlation between symptoms and improved electrodiagnostic parameters with supplementation. Other studies failed to measure or estimate B6 levels. Nevertheless, it appears reasonable to recommend vitamin B6 supplementation to people with CTS. Some patients will improve symptomatically with low risks of toxicity in recommended doses.
Asunto(s)
Síndrome del Túnel Carpiano/tratamiento farmacológico , Piridoxina/uso terapéutico , Deficiencia de Vitamina B 6/tratamiento farmacológico , Síndrome del Túnel Carpiano/diagnóstico , Síndrome del Túnel Carpiano/etiología , Suplementos Dietéticos , Humanos , Resultado del Tratamiento , Deficiencia de Vitamina B 6/complicaciones , Deficiencia de Vitamina B 6/diagnósticoRESUMEN
Pyridoxine-dependent seizures are an extremely rare genetic disorder. Early diagnosis and treatment are important for the prevention of permanent brain damage. Elevated levels of glutamate and decreased levels of gamma-aminobutyric acid (GABA) in the frontal and parietal cortices are among the characteristic features of this disorder. These metabolic abnormalities eventually lead to seizures and neuronal loss. In this case report, we present magnetic resonance spectroscopy findings of a 9-year-old girl with pyridoxine-dependent seizures with mental retardation. The N-acetylaspartate-to-creatine ratio was found to be decreased in the frontal and parieto-occipital cortices, which could indicate neuronal loss. Magnetic resonance spectroscopy could be a useful tool in the neuroimaging evaluation for assessment of parenchymal changes despite a normal-appearing brain magnetic resonance image in patients with pyridoxine-dependent seizures.
Asunto(s)
Ácido Aspártico/análogos & derivados , Daño Encefálico Crónico/genética , Epilepsia Generalizada/genética , Lóbulo Frontal/patología , Ácido Glutámico/metabolismo , Discapacidad Intelectual/genética , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , Lóbulo Parietal/patología , Deficiencia de Vitamina B 6/genética , Ácido gamma-Aminobutírico/deficiencia , Ácido Aspártico/metabolismo , Daño Encefálico Crónico/diagnóstico , Daño Encefálico Crónico/tratamiento farmacológico , Niño , Colina/metabolismo , Consanguinidad , Creatina/metabolismo , Diagnóstico Diferencial , Epilepsia Generalizada/diagnóstico , Epilepsia Generalizada/tratamiento farmacológico , Femenino , Estudios de Seguimiento , Humanos , Inositol/metabolismo , Discapacidad Intelectual/diagnóstico , Discapacidad Intelectual/tratamiento farmacológico , Lóbulo Occipital/patología , Fosfocreatina/metabolismo , Piridoxina/administración & dosificación , Valores de Referencia , Deficiencia de Vitamina B 6/diagnóstico , Deficiencia de Vitamina B 6/tratamiento farmacológico , Ácido gamma-Aminobutírico/metabolismoRESUMEN
OBJECTIVE: To assess the association between preconception homocysteine and B vitamin status and risk of clinical spontaneous abortion in women from Anqing, China. METHODS: All women were aged 21-34 years, had never smoked, and were primigravid. Patients (n = 49) were women with a clinically recognized pregnancy who experienced a fetal death before 100 days' gestation. Controls (n = 409) were women who maintained a pregnancy that ended in a live birth. Homocysteine, folate, and vitamins B(6) and B(12) concentrations were measured in plasma obtained before conception. RESULTS: Mean vitamin B(6) concentration was lower in patients than in controls (34.0 versus 37.9 nmol/L, P =.04). In addition, the risk of spontaneous abortion tended to increase with decreasing plasma vitamin B(6) and folate concentration (P for trend =.06 and.07, respectively), although the significance of these trends was further reduced in logistic models that included age, body mass index, and both vitamins. The risk of spontaneous abortion was four-fold higher among women with suboptimal plasma concentrations of both folate and vitamin B(6) (folate less than or equal to 8.4 nmol/L and vitamin B(6) less than or equal to 49 nmol/L) than in those with higher plasma concentrations of both vitamins (odds ratio 4.1, 95% confidence interval 1.2, 14.4). Homocysteine and vitamin B(12) status were not associated with spontaneous abortion risk. CONCLUSION: Suboptimal preconception folate and vitamin B(6) status, especially when they occur together, may increase the risk of clinical spontaneous abortion. Additional prospective studies are needed to confirm these findings and to determine whether antenatal B vitamin supplementation reduces spontaneous abortion risk.
Asunto(s)
Aborto Espontáneo/epidemiología , Ácido Fólico/análisis , Vitamina B 6/análisis , Aborto Espontáneo/etiología , Adulto , Estudios de Casos y Controles , China/epidemiología , Estudios de Cohortes , Femenino , Fertilización , Deficiencia de Ácido Fólico/complicaciones , Deficiencia de Ácido Fólico/diagnóstico , Humanos , Incidencia , Atención Prenatal , Probabilidad , Valores de Referencia , Factores de Riesgo , Estadísticas no Paramétricas , Deficiencia de Vitamina B 6/complicaciones , Deficiencia de Vitamina B 6/diagnósticoAsunto(s)
Metilación de ADN , Deficiencia de Ácido Fólico , Metionina/deficiencia , Selenio/deficiencia , Deficiencia de Vitamina B 12 , Deficiencia de Vitamina B 6 , Deficiencia de Ácido Fólico/diagnóstico , Deficiencia de Ácido Fólico/prevención & control , Deficiencia de Ácido Fólico/terapia , Enfermedades Hematológicas/diagnóstico , Enfermedades Hematológicas/prevención & control , Enfermedades Hematológicas/terapia , Humanos , Hiperhomocisteinemia/diagnóstico , Hiperhomocisteinemia/prevención & control , Enfermedad Iatrogénica/prevención & control , Metilación , Neoplasias/diagnóstico , Neoplasias/prevención & control , Enfermedades del Sistema Nervioso/diagnóstico , Enfermedades del Sistema Nervioso/prevención & control , Enfermedades Vasculares/diagnóstico , Enfermedades Vasculares/prevención & control , Deficiencia de Vitamina B 12/diagnóstico , Deficiencia de Vitamina B 12/prevención & control , Deficiencia de Vitamina B 12/terapia , Deficiencia de Vitamina B 6/diagnóstico , Deficiencia de Vitamina B 6/prevención & control , Deficiencia de Vitamina B 6/terapiaRESUMEN
Polyneuropathy is one of the most frequent manifestations in chronic uremia. Among the factors related to polyneuropathy, vitamin B6 deficiency is well known. The exact prevalence of vitamin B6 deficiency related to neurological manifestations has not been previously reported. We studied vitamin B6 status, collected self-reported symptoms, and carried out full neurological examinations in 66 patients on chronic peritoneal dialysis. Vitamin B6 status was estimated by direct measurement of pyridoxal phosphate. In general, symptoms related to vitamin B6 deficiency are peripheral neuropathies, such as paresthesia, burning and painful dysesthesias, and thermal sensations. These symptoms were reported and assigned one of five grade scores. Of our 66 patients, 12 patients complained at least one sensory abnormality. The levels of vitamin B6 in the patients varied between 1.0 ng/mL and 30 ng/mL. Patients who complained of neurological symptoms owing to vitamin B6 deficiency were significantly older than the other patients. In analyzing the symptomatic cases before and after vitamin B6 supplementation, a significant correlation was seen between the level of vitamin B6 and symptoms. Within one month after initiation of oral vitamin B6 supplementations (30 mg daily), levels of pyridoxal phosphate rose, and sensory abnormalities improved in 8 of 12 patients. When peripheral neuropathy is suspected in elderly patients on chronic peritoneal dialysis, vitamin B6 deficiency should be taken into consideration as the cause. If vitamin B6 deficiency is appropriately treated by oral supplementation, sensory abnormalities can be eliminated.
Asunto(s)
Diálisis Peritoneal , Deficiencia de Vitamina B 6/diagnóstico , Adolescente , Adulto , Factores de Edad , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Parestesia/diagnóstico , Parestesia/etiología , Diálisis Peritoneal/efectos adversos , Polineuropatías/sangre , Polineuropatías/etiología , Fosfato de Piridoxal/sangre , Piridoxina/administración & dosificación , Piridoxina/sangre , Vitamina B 12/sangre , Deficiencia de Vitamina B 6/etiología , Deficiencia de Vitamina B 6/terapiaRESUMEN
The unexpected autopsy finding of Wernicke encephalopathy in three children who died after prolonged enteral feeding prompted us to examine the incidence of thiamine deficiency in three high-risk pediatric populations. We also measured riboflavin and pyridoxine activity in the same groups. We used activated enzyme assays (erythrocyte transketolase, glutathione reductase, aspartate aminotransferase) to assess tissue stores of the dependent vitamin cofactors (thiamine (vitamin B1), riboflavin (vitamin B2), and pyridoxine (vitamin B6), respectively). Using our own reference ranges based on data from 80 healthy adults and children, we prospectively investigated the B vitamin status of three groups of children: (1) 27 patients who were fed solely by nasogastric tube for more than 6 months, (2) 80 children admitted to a pediatric intensive care unit for more than 2 weeks, and (3) 6 children receiving intensive chemotherapy. The upper limits for stimulated enzyme activity in control subjects were unaffected by age or gender (16% for transketolase, 63% for glutathione reductase, 123% for aspartate aminotransferase). Using these limits, 10 (12.5%) of 80 patients receiving intensive care and 4 of 6 patients receiving chemotherapy were thiamine deficient. Elevated levels returned to normal after thiamine supplementation. No patients were pyridoxine deficient, but 3 (3.8%) of the 80 patients receiving intensive care and 1 of the 6 patients receiving chemotherapy were also riboflavin deficient. We conclude that unrecognized thiamine deficiency is common in our pediatric intensive care and oncology groups. This potentially fatal but treatable disease can occur in malnourished patients of any age and is probably underdiagnosed among chronically ill children. Our findings may be applicable to other high-risk pediatric groups.
Asunto(s)
Aspartato Aminotransferasas/sangre , Enfermedad Crítica , Nutrición Enteral/efectos adversos , Glutatión Reductasa/sangre , Deficiencia de Tiamina/diagnóstico , Transcetolasa/sangre , Vómitos/complicaciones , Adolescente , Adulto , Niño , Preescolar , Pruebas Enzimáticas Clínicas , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Femenino , Humanos , Lactante , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Deficiencia de Riboflavina/diagnóstico , Deficiencia de Tiamina/etiología , Deficiencia de Vitamina B 6/diagnósticoRESUMEN
The role of protein and calorie deficiency in sickle cell disease remains poorly defined. While such features as growth retardation, impaired immune function, and delayed menarche do suggest a relationship between sickle cell disease and undernutrition, measurement of more direct nutritional parameters in these patients have yielded mixed results. Anthropometric measurements such as skinfold thickness are subnormal in many but not all reports. Serum protein levels are normal, but low values for serum lipids have been reported. Finally, one small study shows an improvement in both growth parameters and clinical course following caloric supplementation. A variety of micronutrient deficiencies have been suggested in sickle cell disease. Numerous case reports describing an exacerbation of the chronic anemia that was reversed by folic acid therapy led to routine folate supplementation. More recent studies have shown, however, that clinically significant folic acid deficiency occurs only in a small minority of sickle cell patients. Clearly, more work is necessary to define the cost/benefit ratio of routine folic acid supplementation. Pharmacological amounts of vitamin B6 and certain of its derivatives possess in vitro antisickling activities. Nevertheless, a small clinical trial failed to demonstrate any consistent hematologic effects of B6 supplementation. Several reports indicate that vitamin E levels are low in sickle erythrocytes. Since these abnormal red cells both generate excessive oxidation products and are more sensitive to oxidant stress, and because oxidants appear to play a role in ISC formation, vitamin E deficiency could well be linked to ISC formation and hemolysis. Small clinical trials, however, have again failed to produce a clear hematological response in sickle cell anemia. The role of zinc in sickle cell disease has received considerable attention. Though studies are generally small, most do support a relationship between sickle cell disease and zinc deficiency. Etiologic associations between zinc deficiency and such complications of sickle cell disease as poor ulcer healing, growth retardation, delays in sexual development, immune deficiencies, and high ISC counts have all been suggested. Most of these studies need further corroboration. Iron deficiency is now known to be a relatively common occurrence in sickle cell anemia, especially in children and pregnant women. The theoretical benefits of concomitant iron deficiency and sickle cell anemia remain to be proven in a controlled clinical trial.(ABSTRACT TRUNCATED AT 400 WORDS)
Asunto(s)
Anemia de Células Falciformes , Alimentos , Rasgo Drepanocítico , Anemia de Células Falciformes/sangre , Anemia de Células Falciformes/metabolismo , Anemia de Células Falciformes/fisiopatología , Avitaminosis/diagnóstico , Ácido Fólico/uso terapéutico , Humanos , Minerales/deficiencia , Minerales/metabolismo , Estado Nutricional , Piridoxina/uso terapéutico , Rasgo Drepanocítico/sangre , Rasgo Drepanocítico/metabolismo , Rasgo Drepanocítico/fisiopatología , Deficiencia de Vitamina B 6/diagnóstico , Deficiencia de Vitamina E/diagnóstico , Vitaminas/metabolismo , Zinc/deficienciaRESUMEN
The role of insufficient pyridoxine as an etiologic factor in the development of carpal tunnel syndrome (CTS) has been reported and has led to the empirical use of pyridoxine to treat CTS. Previous studies have not employed standardized electrodiagnostic criteria to objectively determine the presence of CTS or to rule out peripheral neuropathy (PN). The present study categorized subjects with symptoms suggestive of CTS into four groups by standardized electrodiagnostic criteria: (1) CTS, (2) PN, (3) CTS and PN, (4) normal. At least seven subjects were in each group. Erythrocyte glutamine oxaloacetic acid transaminase (EGOT) activity with and without in vitro enhancement with pyridoxal phosphate was used as a means of identifying subjects with and without pyridoxine metabolic abnormalities. A significant difference in pyridoxine metabolic activity (PMA) was found between groups by both chi square (p less than 0.05) and analysis of variance (p less than 0.05). Further evaluation showed that this difference was associated with the presence or absence of PN (p less than 0.05). There was no difference in PMA when groups were separated on the basis of CTS. Results showed that a PMA abnormality was a factor highly correlated with the presence of PN but not CTS. This finding suggested that the positive response reported previously in subjects with CTS taking supplemental pyridoxine may actually be related to an unrecognized PN, which was compounding the symptomatology.
Asunto(s)
Síndrome del Túnel Carpiano/sangre , Enfermedades del Sistema Nervioso Periférico/sangre , Piridoxina/sangre , Aspartato Aminotransferasas/sangre , Síndrome del Túnel Carpiano/diagnóstico , Electromiografía , Eritrocitos/enzimología , Femenino , Humanos , Técnicas In Vitro , Masculino , Persona de Mediana Edad , Examen Neurológico , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Fosfato de Piridoxal , Temperatura Cutánea , Deficiencia de Vitamina B 6/sangre , Deficiencia de Vitamina B 6/diagnósticoRESUMEN
The concept of this basic research was that monosodium L-glutamate could reveal a deficiency of vitamin B6 by the neurological reactions known as the Chinese Restaurant Syndrome. An other amino acid, tryptophan, administered to subjects, is known to reveal a deficiency of vitamin B6 by the excretory xanthurenic acid, etc. The presence and degree of a deficiency of vitamin B6 in 155 students on no supplemental B6 was determined by the differential assay of aspartate transaminase of erythrocytes which also allows each subject to be a control. Twenty-seven of 155 students had extraordinarily low basal specific activities of the transaminase, less than 0.26 mumol pyruvate/(h X 10(8) erythrocytes). These 27 were challenged with glutamate and a placebo. Twelve of 27 revealed the Chinese Restaurant Syndrome, and 15 did not. By double blind trials, the 12 "responders" were treated with pyridoxine and a placebo for twelve weeks, and then were rechallenged with glutamate and a placebo. Decoding showed 3 of 12 received placebo to pyridoxine and then revealed the symptoms of the syndrome again to glutamate; 9 of 12 received pyridoxine and then 8 of 9 failed to respond to glutamate. These results show, p less than 0.01, that the symptoms of the Chinese Restaurant Syndrome to oral glutamate fail to reoccur after treatment which pyridoxine, and that the biochemistry of vitamin B6 is basic to the cause of the Chinese Restaurant Syndrome.